Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Quetiapine fumarate
Drug ID BADD_D01889
Description Initially approved by the FDA in 1997, quetiapine is a second-generation atypical antipsychotic used in schizophrenia, major depression, and bipolar disorder.[L8546] Quetiapine demonstrates a high level of therapeutic efficacy and low risk of adverse effects during long-term treatment. It is well-tolerated and a suitable option for some patients with high sensitivity to other drugs, such as [Clozapine] and [Olanzapine].[A2189]
Indications and Usage For the treatment of schizophrenia and related psychotic disorders.
Marketing Status Prescription; Discontinued
ATC Code N05AH04
DrugBank ID DB01224
KEGG ID D00458
MeSH ID D000069348
PubChem ID 441261
TTD Drug ID D0H7KF
NDC Product Code 67877-249; 71335-0772; 52817-162; 29300-150; 50268-634; 70518-1018; 50090-3342; 68180-613; 63629-4776; 12780-4930; 0904-6642; 59765-145; 65862-493; 70518-2102; 0904-6643; 65015-699; 52817-163; 16571-720; 70518-2522; 14799-1102; 62331-039; 50268-630; 67296-1243; 50742-639; 59765-146; 34908-639; 65862-495; 71335-1519; 55111-190; 51407-068; 68180-449; 16729-097; 65862-494; 68554-0024; 65862-490; 68180-447; 34908-636; 59765-150; 63739-677; 68554-0089; 65862-489; 71610-128; 71610-141; 16729-096; 0781-5344; 55700-941; 69037-0064; 0904-6641; 34908-638; 71610-136; 55111-189; 68001-514; 55111-186; 50268-632; 50090-3198; 16571-717; 70518-2502; 49711-1506; 16364-146; 63187-219; 0781-5343; 33342-104; 50742-638; 68001-511; 51407-074; 13668-153; 61919-911; 70518-2701; 16364-149; 0904-6638; 16571-722; 47335-905; 29300-148; 71335-0926; 29300-149; 68180-445; 29300-147; 50268-631; 47335-907; 70518-0645; 70518-2016; 65862-492; 51407-073; 16436-0061; 0904-6801; 15894-0005; 52817-160; 68071-1892; 16729-109; 16571-721; 47335-903; 70518-2672; 29300-152; 0054-0229; 55111-188; 0781-5346; 52817-161; 46708-863; 51407-076; 67877-246; 52817-164; 47335-902; 71335-1353; 55289-187; 70518-2424; 67877-247; 33342-103; 46708-139; 65096-0106; 71205-031; 59765-147; 70518-2466; 68180-448; 71335-1562; 50090-3983; 67877-250; 0904-6640; 16571-718; 16571-809; 71335-1462; 66651-910; 51407-066; 0904-6805; 50090-3540; 67877-242; 67296-1582; 67877-248; 53747-101; 63629-4964; 68180-446; 55111-053; 55111-249; 50090-3333; 70518-1841; 46708-137; 55111-606; 50090-4022; 43353-008; 70518-1034; 55154-7894; 70518-2752; 33342-100; 65862-491; 0904-6802; 70518-2726; 72189-340; 63629-4841; 59765-149; 59285-024; 68180-450; 50090-5442; 50090-3379; 16729-132; 68069-0006; 71610-127; 0904-6639; 67296-1394; 51407-077; 38779-3081; 43353-957; 47335-906; 77777-114; 59765-148; 13668-148; 0904-6803; 55700-903; 51407-067; 43353-004; 50090-5473; 68788-7960; 68788-9487; 46708-136; 13668-150; 13668-151; 53296-0061; 11712-700; 33342-105; 33342-099; 22365-009; 63187-269; 15308-0320; 67877-245; 70518-2702; 70518-1918; 55289-447; 71335-1362; 73005-0003; 68001-513; 68788-7813; 34908-637; 0054-0221; 46708-135; 62756-628; 51407-075; 70518-2454; 50742-637; 70518-0974; 0904-6804; 51407-071; 76072-1009; 63187-452; 16364-148; 0781-5347; 50090-5884; 68180-612; 63739-665; 71052-653; 0054-0220; 70518-2523; 67296-1336; 50923-0483; 71610-140; 71335-1709; 16364-145; 43353-955; 50090-3303; 52932-0735; 55111-169; 55154-8092; 50742-635; 50268-633; 65372-1114; 50268-635; 33342-101; 50742-636; 16364-147; 65862-262; 70518-3190; 80425-0186; 68001-515; 13668-152; 0781-5342; 68180-615; 51407-069; 63739-690; 0054-0230; 12666-0008; 46708-138; 47335-904; 68788-7950; 29300-151; 16729-095; 0781-5348; 43353-011; 55154-7881; 13668-149; 51407-070; 68180-614; 68788-8065; 66577-033; 46708-134; 48087-0068; 68180-616; 16571-719; 70518-2901; 68001-512; 55289-872; 16364-150; 55154-3359; 50090-3377; 70518-0975; 0781-5345; 60429-416; 80425-0184; 0054-0222; 0054-0223
Synonyms Quetiapine Fumarate | Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt) | Seroquel | ICI 204,636 | ICI-204636 | ICI204636 | ICI 204636 | Quetiapine | 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol
Chemical Information
Molecular Formula C46H54N6O8S2
CAS Registry Number 111974-72-2
SMILES C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4= CC=CC=C42.C(=CC(=O)O)C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Back pain15.03.04.005--
Blepharitis06.04.04.001; 23.03.04.012--Not Available
Blood cholesterol increased13.12.01.002--
Blood creatinine increased13.13.01.004--
Blood pressure increased13.14.03.005--Not Available
Bone pain15.02.01.001--
Bradycardia02.03.02.002--Not Available
Bruxism19.11.03.001; 07.01.06.008--Not Available
Buccoglossal syndrome17.01.02.013; 07.14.02.010--Not Available
Bundle branch block02.03.01.009--Not Available
Cardiac failure congestive02.05.01.002--Not Available
Cardiomyopathy02.04.01.001--Not Available
Catatonia19.11.01.001--Not Available
Cerebral ischaemia24.04.06.003; 17.08.01.005--
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Chills15.05.03.016; 08.01.09.001--
Choreoathetosis17.01.01.003--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Conjunctivitis11.01.06.012; 06.04.01.002--
Constipation07.02.02.001--
Coordination abnormal17.02.02.004--Not Available
Cough22.02.03.001--
Cyanosis24.03.01.007; 22.02.02.007; 02.01.02.002--
Cystitis20.03.02.002; 11.01.14.001--
Deafness04.02.01.001--Not Available
Dehydration14.05.05.001--
Delirium19.13.02.001--
Delusion19.10.01.001--
Dental caries07.09.01.001--
Depression19.15.01.001--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 9 Pages